Sarah Klein

Sarah Klein currently serves as a Clinical Biomarker and Diagnostics Operations Senior Associate at Amgen, a position held since February 2024. Prior to this, Sarah Klein was with Rebiotix Inc (a Ferring Company) from June 2016 to February 2024, holding roles including Biosample Operations Manager and Associate Scientist II. Responsibilities included managing patient sample programs, facilitating collaboration between Clinical and R&D departments, and authoring reports for clinical studies. Sarah Klein has a strong background in R&D, particularly in the development of the RBX7455 oral formulation, and has contributed to various research projects and studies throughout a comprehensive career that began with a BA in Biology from Macalester College in 2017. Other experiences include internships at the Mayo Clinic and Universidad de Granada, focusing on research and project management in biomedical contexts.